
Chai-2: The AI Model Accelerating Drug Discovery with Chai Discovery Co-Founders Jack Dent and Joshua Meier
No Priors: Artificial Intelligence | Technology | Startups
00:00
The Future of Biotech and AI in Drug Discovery
This chapter explores the potential advancements in the biotech industry over the next 25 years, focusing on the optimistic developments in drug discovery driven by AI and innovative technologies. It discusses the complexities of drug design, the importance of interdisciplinary collaboration, and the impact of advanced AI models on antibody engineering. The conversation highlights strategic decision-making, the necessity for efficient operations, and the importance of user-friendly software in transforming the pharmaceutical landscape.
Transcript
Play full episode